Chan Zuckerberg Biohub Inc is located in San Francisco, CA. The organization was established in 2016. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2022, Chan Zuckerberg Biohub Inc employed 202 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Chan Zuckerberg Biohub Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Chan Zuckerberg Biohub Inc generated $16.4m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (39.9%) each year. All expenses for the organization totaled $90.8m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Chan Zuckerberg Biohub Inc has awarded 24 individual grants totaling $148,172,236. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
CONDUCT CUTTING EDGE MEDICAL RESEARCH
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN 2022 THE CHAN ZUCKERBERG BIOHUB, INC. ("CZ BIOHUB") CELEBRATED ITS 6TH ANNIVERSARY AS A MEDICAL RESEARCH ORGANIZATION. CONSISTENT WITH OUR MISSION, WE CONTINUED TO FOCUS ON LARGE-SCALE SCIENTIFIC INITIATIVES THAT WE ARE UNIQUELY POSITIONED TO SUPPORT AND EXECUTE, EACH ON A MULTI-YEAR TIMELINE:1. INTRAMURAL RESEARCH PROJECTS LED BY CZ BIOHUB RESEARCHERS THAT EMPHASIZE BASIC SCIENCE, IN TWO MAIN AREAS:A. QUANTITATIVE CELL SCIENCEB. INFECTIOUS DISEASE2. PROGRAMS SUPPORTING SCIENTISTS AND PHYSICIANS AT OUR INSTITUTIONS UNIVERSITIES (STANFORD UNIVERSITY; UC SAN FRANCISCO; UC BERKELEY) THROUGH THE CZ BIOHUB INVESTIGATOR PROGRAM, PHYSICIAN-SCIENTIST FELLOWSHIP PROGRAM, AND COLLABORATIVE POSTDOCTORAL FELLOWSHIP PROGRAM.HIGHLIGHTS- IN MARCH 2022, THE PAPER DESCRIBING OPENCELL - AN OPEN-SOURCE, PROTEOME-SCALE COLLECTION OF PROTEIN LOCALIZATION AND INTERACTION MEASUREMENTS IN HUMAN CELLS - WAS PUBLISHED IN SCIENCE, AND HAS SINCE BEEN DOWNLOADED MORE THAN 31,000 TIMES. THE OPENCELL'S ALTMETRIC SCORE IS 433, PLACING IT IN THE TOP 5% OF ALL RESEARCH OUTPUTS TRACKED BY ALTMETRIC. FOR THIS ACHIEVEMENT AND HIS LARGER BODY OF WORK, CZ BIOHUB SF SCIENTIST MANUEL LEONETTI WON THE INNOVATION IN RESEARCH AWARD FROM THE AMERICAN SOCIETY FOR CELL BIOLOGY, A DISTINCTION THAT "RECOGNIZES EARLY AND MID-CAREER SCIENTISTS FOR THEIR NEW AND INNOVATIVE RESEARCH IN CELL BIOLOGY."- THE TABULA SAPIENS, A SINGLE-CELL ATLAS OF MORE THAN 400 HUMAN CELL TYPES BASED ON ANALYSIS OF NEARLY 500,000 CELLS FROM MULTIPLE ORGANS, WAS PUBLISHED IN SCIENCE IN MAY 2022. THE PAPER HAS SINCE BEEN DOWNLOADED NEARLY 120,000 TIMES, AND HAS AN ALTMETRIC SCORE OF 1158, PLACING IT IN THE TOP 5% OF ALL RESEARCH OUTPUTS TRACKED BY ALTMETRIC.- OUR RAPID RESPONSE TEAM TRAINED VISITING SCIENTIFIC TEAMS FROM ZAMBIA, PAKISTAN, CAMBODIA, AND BANGLADESH IN METAGENOMIC NEXT-GENERATION SEQUENCING TECHNIQUES AND THE USE OF CZ ID, AN OPEN-SOURCE WEB PORTAL AND DATABASE TO TRACK AND IDENTIFY PATHOGENS IN THEIR RESPECTIVE COUNTRIES AND RESPOND TO INFECTIOUS DISEASE OUTBREAKS.- IN JANUARY 2022, WE ANNOUNCED OUR SECOND COHORT OF CZ BIOHUB INVESTIGATORS, 86 SCIENTISTS WORKING IN DIVERSE FIELDS AT STANFORD, UCSF, AND UC BERKELEY SUPPORTED BY UNRESTRICTED RESEARCH GRANTS FROM THE BIOHUB.- THROUGH OUR COLLABORATIVE POSTDOCTORAL FELLOWSHIP PROGRAM, WE SUPPORTED INTERDISCIPLINARY, COLLABORATIVE RESEARCH BY SEVEN FELLOWS IN LABS AT ALL THREE OF OUR PARTNER UNIVERSITIES. OUR PHYSICIAN-SCIENTIST FELLOWSHIP PROGRAM TRAINED SIX PHYSICIANS AT UCSF AND STANFORD UNIVERSITY IN BIOMEDICAL RESEARCH TECHNIQUES (BOTH LABORATORY AND COMPUTATIONAL) THROUGH AN IMMERSIVE, HANDS-ON EXPERIENCE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Joseph Derisi Co-President & Director | OfficerTrustee | 40 | $848,528 |
Steve Quake Co-President & Director | OfficerTrustee | 10 | $581,077 |
Cori Bargmann Director | Trustee | 3 | $0 |
John Hennessy Director | Trustee | 3 | $0 |
Mark Zuckerberg Director | Trustee | 3 | $0 |
Priscilla Chan Director | Trustee | 3 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Arnold & Porter Kaye Scholer Llp Legal Services | 12/30/22 | $1,275,293 |
Kilpatrick Townsend Legal Services | 12/30/22 | $679,791 |
Nexus Contingent Workforce Temporary Services | 12/30/22 | $575,528 |
Marshall Gerstein & Borun Llp Legal Services | 12/30/22 | $440,887 |
Graham Adair Legal Services | 12/30/22 | $304,823 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $5,000,000 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $9,330,487 |
Noncash contributions included in lines 1a–1f | $883,433 |
Total Revenue from Contributions, Gifts, Grants & Similar | $14,330,487 |
Total Program Service Revenue | $750,912 |
Investment income | $891,383 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $437,199 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $16,409,981 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $29,060,304 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $6,293,643 |
Compensation of current officers, directors, key employees. | $2,960,381 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $18,710,170 |
Pension plan accruals and contributions | $918,138 |
Other employee benefits | $2,610,612 |
Payroll taxes | $1,505,542 |
Fees for services: Management | $0 |
Fees for services: Legal | $3,047,033 |
Fees for services: Accounting | $229,643 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $3,775,919 |
Advertising and promotion | $23,757 |
Office expenses | $2,201,774 |
Information technology | $2,116,374 |
Royalties | $0 |
Occupancy | $7,262,555 |
Travel | $632,189 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $821,080 |
Interest | $6,200 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $4,459,322 |
Insurance | $263,512 |
All other expenses | $0 |
Total functional expenses | $90,813,707 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $8,211,743 |
Savings and temporary cash investments | $83,819,723 |
Pledges and grants receivable | $155,925,884 |
Accounts receivable, net | $495,864 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $1,492,771 |
Net Land, buildings, and equipment | $10,981,666 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $1,134,735 |
Intangible assets | $0 |
Other assets | $9,050,044 |
Total assets | $271,112,430 |
Accounts payable and accrued expenses | $3,039,831 |
Grants payable | $6,696,071 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $8,382,566 |
Total liabilities | $18,118,468 |
Net assets without donor restrictions | $91,156,531 |
Net assets with donor restrictions | $161,837,431 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $271,112,430 |
Over the last fiscal year, Chan Zuckerberg Biohub Inc has awarded $29,060,304 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
STANFORD UNIVERSITY PURPOSE: SCIENTIFIC AND MEDICALRESEARCH | $11,215,383 |
UC SAN FRANCISCO PURPOSE: SCIENTIFIC AND MEDICALRESEARCH | $11,796,796 |
UC BERKELEY PURPOSE: SCIENTIFIC AND MEDICALRESEARCH | $6,048,125 |